Debate: Does it matter how you lower blood pressure?

Content Provider	Semantic Scholar
Author	Alderman, Michael H.
Copyright Year	2000
Abstract	Whether it matters how pressure is lowered has been debated since antihypertensive drugs proved to prevent cardiovascular events. However, in clinical trials, while the stroke benefit predicted by a given difference in blood pressure was achieved, the results for myocardial infarction were roughly half that expected. This suggested that adverse drug effects of diuretics and beta-blockers might have detracted from their hypotensive effects. Trials with newer antihypertensive classes have revealed superior effects on outcomes associated with converting enzyme inhibitor use, and that alpha-blockers are less cardioprotective than diuretics. These studies establish that simple blood pressure reduction is an inadequate guide to therapy. The challenge now will be to determine the optimal therapy for each hypertensive patient.
Starting Page	69
Ending Page	71
Page Count	3
File Format	PDF HTM / HTML
PubMed reference number	11714412v1
Volume Number	1
Journal	Current controlled trials in cardiovascular medicine
Alternate Webpage(s)	https://trialsjournal.biomedcentral.com/track/pdf/10.1186/cvm-1-2-069?site=trialsjournal.biomedcentral.com
Language	English
Access Restriction	Open
Subject Keyword	Adrenergic beta-Antagonists Adverse reaction to drug Antihypertensive Agents Cerebrovascular accident Diuretics Enzyme Inhibitors Hypertensive disease Myocardial Infarction Patients
Content Type	Text
Resource Type	Article